Aspen Aerogels Inc. ASPN
RETAIL: Building Materials · IPO 2014 · data as of November 13, 2026
Aspen Aerogels Inc. (ASPN) is a consumer discretionary company listed in the US with a market value of about $464M. In the twelve months to September 30, 2026 it had revenue of $214M and net income of -$130M, a net margin of -60.8%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).
Key numbers: a price to free cash flow of 23.3, 5-year revenue growth of 22% a year, a 5-year average ROIC of -26%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 68% below the current price.
About Aspen Aerogels
Aspen Aerogels is listed in the US and classified in retail: building materials, IPO year 2014. Revenue went from $102M in 2014 to $271M in 2025, growth of about 9.3% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 109% over three years (dilution for shareholders). It spends 5% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214M | $271M | $453M | $239M | $180M | $122M | $100M | $139M | $104M | $112M | $118M |
| Net income | -$130M | -$390M | $13M | -$46M | -$83M | -$37M | -$22M | -$15M | -$34M | -$19M | -$12M |
| Free cash flow | $20M | -$5M | -$41M | -$218M | -$272M | -$32M | -$13M | -$3M | -$12M | -$11M | -$14M |
| EPS (diluted) | $-1.58 | $-4.73 | $0.17 | $-0.66 | $-2.10 | $-1.22 | $-0.83 | $-0.60 | $-1.45 | $-0.83 | $-0.52 |
| Net margin | -60.8% | -143.7% | 2.9% | -19.2% | -45.9% | -30.5% | -21.8% | -10.4% | -33.0% | -17.3% | -10.2% |
| ROIC | — | -91.8% | 6.4% | -7.8% | -14.0% | -22.3% | -22.4% | -16.6% | -33.3% | -14.4% | -7.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $7.75, 39% above the current price; targets range from $5.00 to $10.00; the consensus rating is “Buy”; expected EPS is $-0.27 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Aspen Aerogels stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 68% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Aspen Aerogels pay a dividend?
Not currently.
Is Aspen Aerogels a good stock to buy?
We do not give buy or sell advice. Aspen Aerogels scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.